Selected research
Market Analysis & Forecast
Global Microorganisms Development Services Market Analysis and Forecast 2026-2032
Market perspective
The global Microorganisms Development Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Microorganisms Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Microorganisms Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Microorganisms Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Microorganisms Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Microorganisms Development Services include BRAIN Biotech, WuXi Biologics, KBI Biopharma, Lonza, Evonik, Lallemand Inc, Creative Biogene, MDG Bio and Creative BioMart Microbe, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Microorganisms Development Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Microorganisms Development Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Microorganisms Development Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microorganisms Development Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microorganisms Development Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microorganisms Development Services revenue, projected growth trends, production technology, application and end-user industry.
Microorganisms Development Services Segment by Company
BRAIN Biotech
WuXi Biologics
KBI Biopharma
Lonza
Evonik
Lallemand Inc
Creative Biogene
MDG Bio
Creative BioMart Microbe
Meurice R&D
BOC Sciences
Esco Aster
Microorganisms Development Services Segment by Type
Gene Editing and Synthesis Services
Directed Evolution and Screening Services
Metabolic Pathway Reconstruction Services
Fermentation Process Development Services
Others
Microorganisms Development Services Segment by Application
Biopharmaceuticals
Food and Ingredients
Agriculture and Environment
Energy and Materials
Others
Microorganisms Development Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microorganisms Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microorganisms Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microorganisms Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Microorganisms Development Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Microorganisms Development Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microorganisms Development Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Editing and Synthesis Services
- Directed Evolution and Screening Services
- Metabolic Pathway Reconstruction Services
- Fermentation Process Development Services
- Others
Applications
- Biopharmaceuticals
- Food and Ingredients
- Agriculture and Environment
- Energy and Materials
- Others
Companies covered
- BRAIN Biotech
- WuXi Biologics
- KBI Biopharma
- Lonza
- Evonik
- Lallemand Inc
- Creative Biogene
- MDG Bio
- Creative BioMart Microbe
- Meurice R&D
- BOC Sciences
- Esco Aster
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Microorganisms Development Services Market by Type
- 1.2.1 Global Microorganisms Development Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Gene Editing and Synthesis Services
- 1.2.3 Directed Evolution and Screening Services
- 1.2.4 Metabolic Pathway Reconstruction Services
- 1.2.5 Fermentation Process Development Services
- 1.2.6 Others
- 1.3 Microorganisms Development Services Market by Application
- 1.3.1 Global Microorganisms Development Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceuticals
- 1.3.3 Food and Ingredients
- 1.3.4 Agriculture and Environment
- 1.3.5 Energy and Materials
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Microorganisms Development Services Market Dynamics
- 2.1 Microorganisms Development Services Industry Trends
- 2.2 Microorganisms Development Services Industry Drivers
- 2.3 Microorganisms Development Services Industry Opportunities and Challenges
- 2.4 Microorganisms Development Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Microorganisms Development Services Market Perspective (2021-2032)
- 3.2 Global Microorganisms Development Services Growth Trends by Region
- 3.2.1 Global Microorganisms Development Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Microorganisms Development Services Market Size by Region (2021-2026)
- 3.2.3 Global Microorganisms Development Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Microorganisms Development Services Revenue by Players
- 4.1.1 Global Microorganisms Development Services Revenue by Players (2021-2026)
- 4.1.2 Global Microorganisms Development Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Microorganisms Development Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Microorganisms Development Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Microorganisms Development Services Key Players Headquarters & Area Served
- 4.4 Global Microorganisms Development Services Players, Product Type & Application
- 4.5 Global Microorganisms Development Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Microorganisms Development Services Market CR5 and HHI
- 4.6.3 2025 Microorganisms Development Services Tier 1, Tier 2, and Tier 3
5 Microorganisms Development Services Market Size by Type
- 5.1 Global Microorganisms Development Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Microorganisms Development Services Revenue by Type (2021-2032)
- 5.3 Global Microorganisms Development Services Revenue Market Share by Type (2021-2032)
6 Microorganisms Development Services Market Size by Application
- 6.1 Global Microorganisms Development Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Microorganisms Development Services Revenue by Application (2021-2032)
- 6.3 Global Microorganisms Development Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 BRAIN Biotech
- 7.1.1 BRAIN Biotech Company Information
- 7.1.2 BRAIN Biotech Business Overview
- 7.1.3 BRAIN Biotech Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.1.4 BRAIN Biotech Microorganisms Development Services Product Portfolio
- 7.1.5 BRAIN Biotech Recent Developments
- 7.2 WuXi Biologics
- 7.2.1 WuXi Biologics Company Information
- 7.2.2 WuXi Biologics Business Overview
- 7.2.3 WuXi Biologics Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.2.4 WuXi Biologics Microorganisms Development Services Product Portfolio
- 7.2.5 WuXi Biologics Recent Developments
- 7.3 KBI Biopharma
- 7.3.1 KBI Biopharma Company Information
- 7.3.2 KBI Biopharma Business Overview
- 7.3.3 KBI Biopharma Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.3.4 KBI Biopharma Microorganisms Development Services Product Portfolio
- 7.3.5 KBI Biopharma Recent Developments
- 7.4 Lonza
- 7.4.1 Lonza Company Information
- 7.4.2 Lonza Business Overview
- 7.4.3 Lonza Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Lonza Microorganisms Development Services Product Portfolio
- 7.4.5 Lonza Recent Developments
- 7.5 Evonik
- 7.5.1 Evonik Company Information
- 7.5.2 Evonik Business Overview
- 7.5.3 Evonik Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Evonik Microorganisms Development Services Product Portfolio
- 7.5.5 Evonik Recent Developments
- 7.6 Lallemand Inc
- 7.6.1 Lallemand Inc Company Information
- 7.6.2 Lallemand Inc Business Overview
- 7.6.3 Lallemand Inc Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Lallemand Inc Microorganisms Development Services Product Portfolio
- 7.6.5 Lallemand Inc Recent Developments
- 7.7 Creative Biogene
- 7.7.1 Creative Biogene Company Information
- 7.7.2 Creative Biogene Business Overview
- 7.7.3 Creative Biogene Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Creative Biogene Microorganisms Development Services Product Portfolio
- 7.7.5 Creative Biogene Recent Developments
- 7.8 MDG Bio
- 7.8.1 MDG Bio Company Information
- 7.8.2 MDG Bio Business Overview
- 7.8.3 MDG Bio Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.8.4 MDG Bio Microorganisms Development Services Product Portfolio
- 7.8.5 MDG Bio Recent Developments
- 7.9 Creative BioMart Microbe
- 7.9.1 Creative BioMart Microbe Company Information
- 7.9.2 Creative BioMart Microbe Business Overview
- 7.9.3 Creative BioMart Microbe Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Creative BioMart Microbe Microorganisms Development Services Product Portfolio
- 7.9.5 Creative BioMart Microbe Recent Developments
- 7.10 Meurice R&D
- 7.10.1 Meurice R&D Company Information
- 7.10.2 Meurice R&D Business Overview
- 7.10.3 Meurice R&D Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Meurice R&D Microorganisms Development Services Product Portfolio
- 7.10.5 Meurice R&D Recent Developments
- 7.11 BOC Sciences
- 7.11.1 BOC Sciences Company Information
- 7.11.2 BOC Sciences Business Overview
- 7.11.3 BOC Sciences Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.11.4 BOC Sciences Microorganisms Development Services Product Portfolio
- 7.11.5 BOC Sciences Recent Developments
- 7.12 Esco Aster
- 7.12.1 Esco Aster Company Information
- 7.12.2 Esco Aster Business Overview
- 7.12.3 Esco Aster Microorganisms Development Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Esco Aster Microorganisms Development Services Product Portfolio
- 7.12.5 Esco Aster Recent Developments
8 North America
- 8.1 North America Microorganisms Development Services Revenue (2021-2032)
- 8.2 North America Microorganisms Development Services Revenue by Type (2021-2032)
- 8.2.1 North America Microorganisms Development Services Revenue by Type (2021-2026)
- 8.2.2 North America Microorganisms Development Services Revenue by Type (2027-2032)
- 8.3 North America Microorganisms Development Services Revenue Share by Type (2021-2032)
- 8.4 North America Microorganisms Development Services Revenue by Application (2021-2032)
- 8.4.1 North America Microorganisms Development Services Revenue by Application (2021-2026)
- 8.4.2 North America Microorganisms Development Services Revenue by Application (2027-2032)
- 8.5 North America Microorganisms Development Services Revenue Share by Application (2021-2032)
- 8.6 North America Microorganisms Development Services Revenue by Country
- 8.6.1 North America Microorganisms Development Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Microorganisms Development Services Revenue by Country (2021-2026)
- 8.6.3 North America Microorganisms Development Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Microorganisms Development Services Revenue (2021-2032)
- 9.2 Europe Microorganisms Development Services Revenue by Type (2021-2032)
- 9.2.1 Europe Microorganisms Development Services Revenue by Type (2021-2026)
- 9.2.2 Europe Microorganisms Development Services Revenue by Type (2027-2032)
- 9.3 Europe Microorganisms Development Services Revenue Share by Type (2021-2032)
- 9.4 Europe Microorganisms Development Services Revenue by Application (2021-2032)
- 9.4.1 Europe Microorganisms Development Services Revenue by Application (2021-2026)
- 9.4.2 Europe Microorganisms Development Services Revenue by Application (2027-2032)
- 9.5 Europe Microorganisms Development Services Revenue Share by Application (2021-2032)
- 9.6 Europe Microorganisms Development Services Revenue by Country
- 9.6.1 Europe Microorganisms Development Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Microorganisms Development Services Revenue by Country (2021-2026)
- 9.6.3 Europe Microorganisms Development Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Microorganisms Development Services Revenue (2021-2032)
- 10.2 China Microorganisms Development Services Revenue by Type (2021-2032)
- 10.2.1 China Microorganisms Development Services Revenue by Type (2021-2026)
- 10.2.2 China Microorganisms Development Services Revenue by Type (2027-2032)
- 10.3 China Microorganisms Development Services Revenue Share by Type (2021-2032)
- 10.4 China Microorganisms Development Services Revenue by Application (2021-2032)
- 10.4.1 China Microorganisms Development Services Revenue by Application (2021-2026)
- 10.4.2 China Microorganisms Development Services Revenue by Application (2027-2032)
- 10.5 China Microorganisms Development Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Microorganisms Development Services Revenue (2021-2032)
- 11.2 Asia Microorganisms Development Services Revenue by Type (2021-2032)
- 11.2.1 Asia Microorganisms Development Services Revenue by Type (2021-2026)
- 11.2.2 Asia Microorganisms Development Services Revenue by Type (2027-2032)
- 11.3 Asia Microorganisms Development Services Revenue Share by Type (2021-2032)
- 11.4 Asia Microorganisms Development Services Revenue by Application (2021-2032)
- 11.4.1 Asia Microorganisms Development Services Revenue by Application (2021-2026)
- 11.4.2 Asia Microorganisms Development Services Revenue by Application (2027-2032)
- 11.5 Asia Microorganisms Development Services Revenue Share by Application (2021-2032)
- 11.6 Asia Microorganisms Development Services Revenue by Country
- 11.6.1 Asia Microorganisms Development Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Microorganisms Development Services Revenue by Country (2021-2026)
- 11.6.3 Asia Microorganisms Development Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Microorganisms Development Services Revenue (2021-2032)
- 12.2 SAMEA Microorganisms Development Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Microorganisms Development Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Microorganisms Development Services Revenue by Type (2027-2032)
- 12.3 SAMEA Microorganisms Development Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Microorganisms Development Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Microorganisms Development Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Microorganisms Development Services Revenue by Application (2027-2032)
- 12.5 SAMEA Microorganisms Development Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Microorganisms Development Services Revenue by Country
- 12.6.1 SAMEA Microorganisms Development Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Microorganisms Development Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Microorganisms Development Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst